Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01156480 · ClinicalTrials.gov registry record · NA
Anti-inflammatory Treatment at the Onset of Necrotizing Enterocolitis (NEC) in Preterm Infants
A NA study, sponsored by Endeavor Health.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01156480 is a NA study that was terminated before completion, run by Endeavor Health. The registered enrollment target is 2 participants.
The verdict
NCT01156480, a NA study, was terminated before completion, sponsored by Endeavor Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Despite modern medical advances, necrotizing enterocolitis (NEC) remains a significant problem in neonatal intensive care units (ICUs). Although research has shown NEC to be an inflammatory necrosis of the bowels, to date no study has examined the effect of anti-inflammatory therapy on this dreaded disease once it is diagnosed. The investigators propose a multi-center, randomized, placebo-controlled, double-blinded pilot study to examine the effect of hydrocortisone in infants diagnosed with stages II and III NEC. The investigators will follow C-reactive protein (CRP) levels as a marker of systemic inflammation for the primary outcome in this study.
Interventions
- DRUG placebo
- DRUG hydrocortisone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01156480
The ClinicalTrials.gov registry entry for NCT01156480 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endeavor Health, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01156480 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01156480 about?
NCT01156480 is a clinical study titled "Anti-inflammatory Treatment at the Onset of Necrotizing Enterocolitis (NEC) in Preterm Infants". Despite modern medical advances, necrotizing enterocolitis (NEC) remains a significant problem in neonatal intensive care units (ICUs). Although research has shown NEC to be an inflammatory necrosis of the bowels, to date no study has examined the effect of anti-inflammatory therapy on this dreaded ...
What is the current status of trial NCT01156480?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2009-09. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01156480?
The interventions under investigation include: placebo (DRUG), hydrocortisone (DRUG).
Who is sponsoring clinical trial NCT01156480?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.